Beruflich Dokumente
Kultur Dokumente
Methods and Materials threshold. Succinylcholine (0.51 mg/kg) served as the muscle
relaxant. Atropine (0.4 mg intravenously) was administered
Subjects approximately 2 min before the anesthetic. Patients were oxy-
Sixty-seven patients (30 men, 37 women) with acute psychotic genated from anesthetic administration until postictal resumption
exacerbations and who met the DSM-IV criteria for schizophre- of spontaneous respiration. Bitemporal bilateral electrode place-
nia (American Psychiatric Association 1994) were referred for ment was used throughout. The tourniquet method and two
ECT because of failure to respond to neuroleptic treatment. channels of prefrontal electroencephalogram (EEG) were used to
Psychiatric diagnosis was based on the consensus of three assess seizure duration. An adequate seizure was defined as a
psychiatrists and also had to concur with the patients medical tonic-clonic motor convulsion occurring bilaterally for at least 30
records. Diagnosis in the medical records had to be consistent sec, plus EEG evidence of a cerebral seizure. Reliance on the
throughout the episode of illness. Other inclusion criteria were a duration of motor manifestations to define adequacy was con-
minimum pretreatment score of 37 on the Brief Psychiatric servative because EEG ictal expression typically outlasts motor
Rating Scale (BPRS, 18 items, rated 0 6; Overall and Gorham expression for several seconds (Sackeim et al 1991; Warmflash
1962), and subjects had to be between ages 16 and 50 years. et al 1987). Grossly suprathreshold stimulation can result in
Patients were excluded if they received treatment with depot reduced seizure duration, below conventional cutoffs for ade-
neuroleptics or ECT during the previous 6 months, psychotic quacy (American Psychiatric Association Task Force, in press;
disorders due to a general medical condition, neurologic illness, Sackeim et al 1991); however, it was felt that the stimulus
alcohol or other substance abuse, or serious medical illness. All intensities used here, all adjusted relative to initial seizure
patients had normal results of complete blood count, serum threshold, would be insufficient to result in a marked shortening
electrolytes, and electrocardiography. This study was approved of seizure duration. In each treatment one adequate seizure was
by the Ethics Committee of the Faculty of Medicine of Srina- elicited.
kharinwirot University and the National Review Board of Re- Using the empirical titration technique (Sackeim et al 1987c),
search Studies in Humans of Thailand. After complete descrip- seizure threshold was quantified at the first two treatment
tion of the study and the opportunity to ask questions, voluntary sessions and was defined as the minimal electrical stimulus (in
written informed consent was obtained from the patients or their millicoulombs) to produce a motor seizure duration of at least 30
guardians. sec. For the MECTA SR 1, the titration schedule followed that
Twenty-three patients (10 men, 13 women) were randomized used by Coffey et al (1995). With the Thymatron DGx, the first
to receive low-dosage bilateral ECT (dose just above the seizure stimulus at the first treatment session was 10% of total charge. If
threshold), 23 patients (11 men and 12 women) were assigned to this failed to produce an adequate seizure, electrical dosage was
the twofold seizure threshold group, and 21 patients (9 men and increased in 10% steps. This approach roughly matched the
12 women) were assigned to the fourfold seizure threshold charge delivered by the MECTA SR 1 and Thymatron DGx at
group. Five patients dropped out from this double-blind compar- each step in the titration schedule. There was a limit of four
ative studytwo from the low-dose group, two from the twofold stimulations in a session, but the maximal number administered
seizure threshold group, and one from the fourfold seizure in this sample was three. A 40-sec interval elapsed between each
threshold groupleaving 62 patients in the study. step in the titration, and no patient required additional thiopental.
At the second treatment session, patients were stimulated with
an intensity 5% below the first treatments threshold value. If this
Procedures failed to produce an adequate seizure, the first sessions value
Neuroleptic medications prescribed before the study were dis- was adopted as the initial seizure threshold (ST). Patients were
continued without a washout period. Flupenthixol was started then stimulated with the assigned electrical stimulus charge
before the first ECT session and was continued throughout the (either 1, or 2, or 4 ST). If the decreased intensity produced an
study. The dosage schedule of flupenthixol was fixed at 12 adequate seizure, this new value was taken as the ST, and there
mg/day (600 mg chlorpromazine [CPZ] equivalents) during the was no further stimulation in that session. At subsequent sessions
first week, 18 mg/day (900 mg CPZ equivalents) for the days in the 1 ST group, if needed, electrical stimulus dosage was
8 10, and 24 mg/day (1200 mg CPZ equivalents) thereafter, increased by one step to achieve an adequate seizure. In the 2 ST
depending on tolerability. All patients were treated between and 4 ST groups, the duration of motor seizures was ignored
18 24 mg/day of flupenthixol, which has a half-life of approx- during the three subsequent sessions. Afterward, if the seizure
imately 35 hours, leading to steady state at 7 days. Benzhexol was shorter than 30 sec, the delivered charge was increased by
(4 15 mg/day) was used to manage extrapyramidal symptoms, one step. At the 10th treatment session, all patients were
with dosage titrated on a clinical basis. Diazepam (10 mg/day) reassessed for ST. The stimulus charge was then adjusted based
was prescribed to control agitation on a PRN basis and was on the assigned ST group or to the maximal charge settings of the
withheld at least 8 hours before each ECT treatment. device.
Electroconvulsive therapy was administered three times per
week. The ECT devices were a Thymatron DGx and MECTA SR
1. Each patient was treated with only one ECT device (two Clinical Evaluation
different hospitals participated in the study, each using a different The criterion for clinical response corresponded to a BPRS score
device). Thiopental (2 4 mg/kg) was used at the lowest dosage of 25 or less, as described elsewhere (Chanpattana 1997). The
to induce general anesthesia, minimizing effects on seizure patients who manifested this level of clinical improvement went
224 BIOL PSYCHIATRY W. Chanpattana et al
2000;48:222228
the stabilization period and were classified as ECT re- sponders treated as censored observations. The survival
sponders. There was no difference in response rate among analysis on number of ECT treatments administered
the three treatment groups [52%, 52%, and 55% for 1 ST, yielded a significant effect of treatment group [Figure 1;
2 ST, and 4 ST, respectively; 2(2) 0.04, ns]. There log-rank 2(2) 25.00, p .0001], as did the analysis of
were 11 patients in each treatment group. The three the number of days in treatment [log-rank 2(2) 24.38,
treatment groups did not differ in any of the demographic p .0001].
or clinical variables listed in Table 1. The extent of clinical improvement was comparable
Table 2 presents the treatment features for the remitted among the three remitter groups. At the end of the study,
patients as a function of the ECT conditions. Compared the 1 ST, 2 ST, and 4 ST remitter groups, respectively, had
with remitters in the low-dosage group, remitters in both 62.6%, 60.8%, and 65.6% reductions in BPRS scores and
the 2 ST and 4 ST groups received fewer ECT treatments 55.5%, 66.7%, and 55.8% increases in GAF scores. In the
at the time of first significant clinical improvement, total sample, ANOVAs were conducted on the percentage
defined as a BPRS score of 25 or less [F(2,30) 18.70, change from baseline to study exit in BPRS, GAF, and
p .0001; 1 ST vs. 2 ST, p .002; 1 ST vs. 4 ST, p MMSE scores, with treatment group and remitter status as
.0001] and had fewer days in ECT treatment [F(2,30)
16.35, p .0001; 1 ST vs. 2 ST, p .003; 1 ST vs. 4 ST,
p .0001]. The 2 ST and 4 ST groups did not differ
significantly in these measures (Table 2), although the
pattern of means suggested more rapid onset of improve-
ment in the 4 ST relative to the 2 ST group (p .19).
At the end of study, the same effects were manifest.
Remitters in both the 2 ST and 4 ST groups received fewer
treatments [F(2,30) 18.70, p .0001; 1 ST vs. 2 ST,
p .002; 1 ST vs. 4 ST, p .0001] and had fewer days
in treatment than remitters in the low-dosage group
[F(2,30) 16.29, p .0001; 1 ST vs. 2 ST, p .003; 1
ST vs. 4 ST, p .0001]. The 2 ST and 4 ST groups did not
differ in these measures (Table 2), although again the 4 ST
group averaged three fewer treatments than did the 2 ST
group (p .13). Including the stabilization phase, remit-
ters in the 1 ST group on average received 18.64 (SD
4.95) treatments, whereas the 2 ST remitters averaged
12.46 (SD 3.75) treatments and the 4 ST remitters Figure 1. KaplanMeier survival plot for cumulative probability
of nonresponse as a function of the number of electroconvulsive
averaged 9.18 (SD 1.47) treatments. therapy (ECT) treatments. Groups were treated just above seizure
These effects were reexamined using survival analysis threshold (1 ST), two times above threshold (2 ST), or four
on the total sample of 62 patients, with ECT nonre- times above threshold (4 ST).
226 BIOL PSYCHIATRY W. Chanpattana et al
2000;48:222228
between-subject factors. In the ANOVA on change in conditions: low-dosage right unilateral ECT, high-dosage
BPRS scores there was only a main effect of remitter right unilateral ECT, low-dosage bilateral ECT, and high-
status [F(1,56) 102.37, p .0001]. Similarly, there was dosage bilateral ECT. They found that regardless of
only a main effect of remitter status in the ANOVA on electrode placement, the high-dosage groups had more
change in GAF scores [F(1,56) 18.23, p .0001]. This rapid improvement than did the low-dosage groups. In
indicated that the treatment groups were equivalent in the addition, low-dosage right unilateral ECT had poor effi-
degree of change in symptoms and functional status. The cacy. In another four-group study, Sackeim et al (in press)
ANOVA on MMSE scores produced no significant ef- found that markedly suprathreshold (6 ST) right unilat-
fects, indicating that change in global cognitive status was eral ECT and moderate dosage (2.5 ST) bilateral ECT
independent of treatment condition and remitter status. were more effective and resulted in more rapid improve-
In the total sample, the three treatment groups did not ment than lower intensity (1.5 ST and 2.5 ST) right
differ in initial seizure threshold [F(2,59) 0.40, p .67] unilateral ECT. Thus, in studies of major depression, there
or in the percentage increase in threshold from the first to have been repeated findings that stimulus intensity im-
tenth treatment [F(2,47) 0.79, p .46; Table 1]. pacts on speed of clinical response. This study extends this
Patients who did or did not achieve remitter status did not observation to patients with schizophrenia.
differ in initial seizure threshold [t(60) 0.45, p .65] or Analyses restricted to the remitter sample and survival
in the increase in threshold [t(48) 0.41, p .68]. analyses of the total sample both supported the conclusion
Although there is some evidence that response to ECT in that higher stimulus intensity resulted in more rapid
major depression is associated with a larger cumulative improvement in patients with schizophrenia. The analyses
seizure threshold increase (Sackeim 1999; Sackeim et al in the remitter sample were particularly critical because
1987b), this does not appear to be the case in comparisons of speed of clinical improvement are most
schizophrenia. relevant when restricted to patients who actually respond
(Laska and Siegel 1995; Nobler et al 1997). This approach
also avoids confounding likelihood of response (efficacy)
Discussion with speed of response (efficiency). There was no evi-
This study found that speed of clinical response to bilateral dence in this study that the stimulus-intensity conditions
ECT in patients with schizophrenia is influenced by the differed in likelihood of response or degree of symptom-
degree to which stimulus dosage exceeds seizure thresh- atic improvement.
old. Both of the high-dosage groups had more rapid An unusual aspect of this study was the use of a 3-week
improvement than did the low-dosage group. The findings stabilization period as a screening method to identify
parallel the results reported in patients with major depres- remitters (Chanpattana 1998, 1999; Chanpattana et al
sion ( Nobler et al 1997; Ottosson 1960; Robin and De 1999a, 1999b). The stabilization period started immedi-
Tissera 1982; Sackeim et al 1993, in press). This is of ately after the first sign of significant clinical improvement
clinical importance because ECT is frequently used when (BPRS 25). Stability of clinical symptoms across these
rapid improvement is needed. This was the first ECT study 3 weeks was required for classification as an ECT remitter.
examining the effect of stimulus intensity in patients with Therefore, ECT remitters in this study maintained clinical
schizophrenia. improvement for a substantial period of time.
Dosage factors, which are known to have greater impact This preliminary study had a number of limitations. A
on the efficacy of right unilateral ECT, may also influence washout period for previous antipsychotic medications
the therapeutic properties of bilateral ECT. In major was not used because all study patients were in psychotic
depression, Ottosson (1960) examined the effects of stim- exacerbations, and many patients were difficult to manage.
ulus dose intensity on the efficacy of bilateral ECT. Lack of a washout may have had a substantial effect on the
Although there was no effect of dosage on response rate, patients initial seizure threshold because many patients
speed of symptom reduction was faster in patients who had prior treatment with low potency neuroleptics (Sack-
received a stimulus intensity that was markedly suprath- eim et al 1991). In contrast, all patients were treated with
reshold. Cronholm and Ottosson (1963) reported that flupenthixol, a typical neuroleptic with a potency about
low-intensity, ultra-brief pulse, bilateral ECT was less 1.5 times that of haloperidol. A fixed titration schedule of
effective than higher intensity, sinusoidal waveform, bi- flupenthixol dosage was used to minimize variability in
lateral ECT. Robin and De Tissera (1982) found that with effects on seizure threshold.
bilateral ECT, high-intensity brief-pulse or chopped sine A structured diagnostic instrument was not used. In-
wave stimulation resulting in faster clinical improvement stead, the diagnosis of schizophrenia was based on the
than did low-intensity brief-pulse stimulation. Sackeim et consensus of at least three psychiatrists, which had to
al (1993) randomly assigned patients to four treatment concur with the patients psychiatric records throughout
ECT Stimulus Intensity BIOL PSYCHIATRY 227
2000;48:222228
the episode of illness. Theoretically, the inclusion in the and Privileging, 2nd ed. Washington, DC: American Psychi-
sample of patients with depressive or manic disorders atric Press.
could account for the concordance of the results with Baudis P (1992): Elektrokonvulsini lecba v Ceske republice v
similar studies major depression. The relatively high letech 19811989. Cesk Psychiatr 88:41 47.
representation of female patients might suggest this pos- Chanpattana W (1997): Continuation ECT in schizophrenia: A
sibility. That the patients presented with schizophrenia is pilot study. J Med Assoc Thai 80:311318.
supported by the average episode duration of approxi- Chanpattana W (1998): Maintenance ECT in schizophrenia: A
pilot study. J Med Assoc Thai 81:1724.
mately 3.5 years (Table 1) and relatively low baseline
scores on the BPRS items of depressive mood, grandios- Chanpattana W (1999): The use of the stabilization period in
electroconvulsive therapy research in schizophrenia: I. A pilot
ity, and excitement, coupled with high scores on tradi- study. J Med Assoc Thai 82:11931199.
tional BPRS positive symptoms of psychosis (data not
Chanpattana W, Chakrabhand S, Kongsakon R, Techakasem P,
shown). Buppanharun W (1999a): The short-term effect of combined
It is well documented that ECT produces cognitive ECT and neuroleptic therapy in treatment-resistant schizo-
impairment (American Psychiatric Association Task phrenia. J ECT 15:129 139.
Force, in press; Sackeim 1992). There were no differences Chanpattana W, Chakrabhand S, Sackeim HA, Kitaroonchai W,
among the treatment groups or among ECT responders Kongsakon R, Techakasem P, et al (1999b): Continuation
and nonresponders in change in MMSE scores. Although ECT in treatment-resistant schizophrenia: A controlled study.
J ECT 15:178 192.
this suggests that the dosage conditions did not differ in
changes in global cognitive status, the MMSE is a measure Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M (1995):
Seizure threshold in electroconvulsive therapy: I. Initial
insensitive to the characteristic effects of ECT on antero- seizure threshold. Biol Psychiatry 37:713720.
grade and retrograde memory (Sobin et al 1995). In major
Cronholm B, Ottosson JO (1963): Ultrabrief stimulus technique
depression, there is evidence that higher stimulus intensity in electroconvulsive therapy, II. Comparative studies of
and longer courses of ECT treatment can result in more therapeutic effects and memory disturbance in treatment of
severe transient cognitive side effects (Sackeim 1992; endogenous depression with the Elther ES electroshock ap-
Sackeim et al 1993). It will be important in future research paratus and Siemens Konvulsator. J Nerv Ment Dis 137:268
to use more sensitive neuropsychologic measures and 276.
determine in patients with schizophrenia whether the Fink M, Sackeim HA (1996): Convulsive therapy in schizophre-
nia? Schizophr Bull 22:2739.
enhancement in speed of response due to higher stimulus
intensity offsets a detrimental effect of cognitive function. Kongsakon R, Vanichtanom R (1994): Assessment of the differ-
ences in MMSE between neurological, psychiatric patients
In summary, this preliminary study indicates that in and normal population. J Rajwithi Hosp 5:99 106.
patients with schizophrenia, electrical dosage impacts on
Krueger RB, Sackeim HA (1995): Electroconvulsive therapy
the speed of clinical response to bilateral ECT. Both the and schizophrenia. In: Hirsch S, Weinberger D, editors.
groups treated at twice and four times seizure threshold Schizophrenia. Oxford, UK: Oxford University Press,
had more rapid improvement than did the low-dosage 503545.
group, who were treated just above seizure threshold. Krystal AD, Coffey CE, Weiner RD, Holsinger T (1998):
Future research should examine the effects of high-dosage Changes in seizure threshold over the course of electrocon-
bilateral ECT on cognitive functions, which should be vulsive therapy affect therapeutic response and are detected
by ictal EEG ratings. J Neuropsychiatry Clin Neurosci
assessed with a comprehensive neuropsychological 10:178 186.
battery.
Laska EM, Siegel C (1995): Characterizing onset in psychophar-
macological trials. Psychopharmacol Bull 31:29 35.
McCall WV, Reboussin DM, Weiner RD, Sackeim HA (in
Supported in part by Grant No. BRG 3980009 from the Thailand press): Titrated, moderately suprathreshold versus fixed, high
Research Fund (WC) and Grant No. R37 MH35636 from the National dose RUL ECT: Acute antidepressant and cognitive effects.
Institute of Mental Health (HAS). The authors thank Wiwat Yatapoot- Arch Gen Psychiatry.
anon, M.D., for technical support and the nursing staff of the Srithunya Nobler MS, Sackeim HA, Moeller JR, Prudic J, Petkova E,
mental hospital. Waternaux C (1997): Quantifying the speed of symptomatic
improvement with electroconvulsive therapy: Comparison of
alternative statistical methods. Convuls Ther 13:208 221.
References Ottosson JO (1960): Experimental studies of the mode of action
American Psychiatric Association (1994): Diagnostic and Sta- of electroconvulsive therapy. Acta Psychiatr Scand Suppl
tistical Manual of Mental Disorders, 4th ed. Washington, DC: 145:1141.
American Psychiatric Press. Overall JF, Gorham DR (1962): The Brief Psychiatric Rating
American Psychiatric Association Task Force (in press): The Scale. Psychol Rep 10:799 812.
Practice of ECT: Recommendations for Treatment, Training Robin A, De Tissera SD (1982): A double-blind controlled
228 BIOL PSYCHIATRY W. Chanpattana et al
2000;48:222228
comparison of the therapeutic effects of low and high energy and safety of electroconvulsive therapy. Psychiatr Clin North
electroconvulsive therapies. Br J Psychiatry 141:357366. Am 14:803 843.
Sackeim HA (1992): The cognitive effects of electroconvulsive Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons
therapy. In: Moos WH, Gamzu ER, Thal LJ, editors. Cogni- L, Moody BJ, et al (1993): Effects of stimulus intensity
tive Disorders: Pathophysiology and Treatment. New York: and electrode placement on the efficacy and cognitive
Marcel Dekker, 183228. effects of electroconvulsive therapy. N Engl J Med 328:
Sackeim HA (1999): The anticonvulsant hypothesis of the 839 846.
mechanisms of action of ECT: Current status. J ECT 15:526. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH,
Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S (1987a): Peyser S, et al (in press): A prospective, randomized, double-
Effects of electrode placement on the efficacy of titrated, blind comparison of bilateral and right unilateral ECT at
low-dose ECT. Am J Psychiatry 144:1449 1455. different stimulus intensities. Arch Gen Psychiatry.
Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S (1987b): Shukla GD (1981): Electroconvulsive therapy in a rural teaching
Studies on dosage, seizure threshold, and seizure duration in general hospital in India. Br J Psychiatry 139:569 571.
ECT. Biol Psychiatry 22:249 268. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ,
Sackeim HA, Decina P, Prohovnik I, Malitz S (1987c): Seizure McElhiney MC (1995): Predictors of retrograde amnesia
threshold in electroconvulsive therapy. Arch Gen Psychiatry following ECT. Am J Psychiatry 152:9951001.
44:355360. Warmflash V, Stricks L, Sackeim HA, Neeley P, Malitz S
Sackeim HA, Devanand DP, Prudic J (1991): Stimulus intensity, (1987): Reliability and validity of measures of seizure dura-
seizure threshold, and seizure duration: Impact on the efficacy tion. Convuls Ther 3:18 25.